NasdaqCM - Nasdaq Real Time Price USD

Pasithea Therapeutics Corp. (KTTA)

0.9560
+0.0954
+(11.09%)
At close: May 16 at 4:00:01 PM EDT
0.9300
-0.03
(-2.72%)
After hours: May 16 at 7:58:30 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
15.0620
Cost of Revenue
131.7780
--
--
113.1950
17.2750
Gross Profit
129.1310
--
--
373.3640
-2.2130
Operating Expense
14,249.9620
14,249.9620
15,979.3610
12,588.9710
4,505.2000
Operating Income
-14,249.9620
-14,249.9620
-15,979.3610
-12,588.9710
-4,507.4130
Net Non Operating Interest Income Expense
423.1840
423.1840
415.3680
0
-0.5080
Other Income Expense
-77.8060
-77.8060
56.2450
861.0860
2,334.4000
Pretax Income
-13,904.5840
-13,904.5840
-15,507.7480
-11,727.8850
-2,173.5210
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-13,904.5840
-13,904.5840
-15,961.6580
-13,936.4520
-2,173.5210
Diluted NI Available to Com Stockholders
-13,904.5840
-13,904.5840
-15,961.6580
-13,936.4520
-2,173.5210
Basic EPS
-12.69
--
-13.01
-11.03
-4.20
Diluted EPS
-12.69
--
-13.01
-11.03
-4.20
Basic Average Shares
1,096.0820
--
1,226.6000
1,262.3390
520.2330
Diluted Average Shares
1,096.0820
--
1,226.6000
1,262.3390
520.2330
Total Operating Income as Reported
-14,249.9620
-14,249.9620
-15,979.3610
-12,588.9710
-4,507.4130
Total Expenses
14,249.9620
14,249.9620
15,979.3610
12,588.9710
4,522.4750
Net Income from Continuing & Discontinued Operation
-13,904.5840
-13,904.5840
-15,961.6580
-13,936.4520
-2,173.5210
Normalized Income
-13,826.7780
-13,826.7780
-15,563.9930
-12,578.3380
-4,507.9210
Interest Income
423.1840
423.1840
415.3680
0
--
Interest Expense
--
--
--
0.1020
0.5080
Net Interest Income
423.1840
423.1840
415.3680
0
-0.5080
EBIT
-14,249.9620
-14,249.9620
-15,979.3610
-12,588.9710
-2,173.0130
EBITDA
-13,600.9330
-13,600.9330
-15,330.9070
-12,583.8770
-2,171.6340
Reconciled Cost of Revenue
131.7780
--
--
113.1950
17.2750
Reconciled Depreciation
649.0290
649.0290
648.4540
5.0940
1.3790
Net Income from Continuing Operation Net Minority Interest
-13,904.5840
-13,904.5840
-15,507.7480
-11,727.8850
-2,173.5210
Total Unusual Items Excluding Goodwill
-77.8060
-77.8060
56.2450
850.4530
2,334.4000
Total Unusual Items
-77.8060
-77.8060
56.2450
850.4530
2,334.4000
Normalized EBITDA
-13,523.1270
-13,523.1270
-15,387.1520
-13,434.3300
-4,506.0340
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABP Abpro Corporation
0.2300
-13.24%
 
QNRX Quoin Pharmaceuticals, Ltd.
7.70
0.00%
 
XLO Xilio Therapeutics, Inc.
0.8594
+7.42%
 
CNSP CNS Pharmaceuticals, Inc.
1.2800
+1.59%
 
KLTO Klotho Neurosciences, Inc.
0.2246
+14.01%
 
ENSC Ensysce Biosciences, Inc.
2.3400
+9.35%
 
ONCO Onconetix, Inc.
0.0847
+13.54%
 
HCWB HCW Biologics Inc.
8.95
+9.15%
 
PLRZ Polyrizon Ltd.
0.0066
-25.84%
 
NCNA NuCana plc
0.0438
-17.98%